171 related articles for article (PubMed ID: 36719144)
1. Immune Modulatory Cell Therapy in Kidney Transplantation: Hints of a Durable Mechanism of Action.
Griffin MD; Perico N; Casiraghi F
J Am Soc Nephrol; 2023 Jan; 34(1):4-7. PubMed ID: 36719144
[No Abstract] [Full Text] [Related]
2. The effectiveness of the combination of rituximab and high-dose immunoglobulin in the immunomodulation of sensitized kidney transplant candidates.
Taber T; Mujtaba MA; Goggins W; Higgins N; Sharfuddin A; Yaqub MS; Mishler D; Book B; Chen J; Lobashevsky A
Clin Transplant; 2013; 27(4):E375-82. PubMed ID: 23721524
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulation role of Th17 and Treg in renal transplantation.
Huang DL; He YR; Liu YJ; He HY; Gu ZY; Liu YM; Liu WJ; Luo Z; Ju MJ
Front Immunol; 2023; 14():1113560. PubMed ID: 36817486
[TBL] [Abstract][Full Text] [Related]
4. Multipotent mesenchymal stromal cells in kidney transplant recipients: The next big thing?
Sergeant E; Buysse M; Devos T; Sprangers B
Blood Rev; 2021 Jan; 45():100718. PubMed ID: 32507576
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells in kidney transplantation.
Casiraghi F; Remuzzi G
Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):40-46. PubMed ID: 30300159
[TBL] [Abstract][Full Text] [Related]
6. [Renal transplantation in 2046: Future and perspectives].
Timsit MO; Branchereau J; Thuret R; Kleinclauss F
Prog Urol; 2016 Nov; 26(15):1132-1142. PubMed ID: 27665406
[TBL] [Abstract][Full Text] [Related]
7. Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation?
Pool M; Leuvenink H; Moers C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540361
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases.
Liu P; Yao L; Hu X; Wang Z; Xiong Z; Jiang Y
J Gastroenterol Hepatol; 2023 Jul; 38(7):1099-1106. PubMed ID: 37271943
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D in solid organ transplantation with special emphasis on kidney transplantation.
Thiem U; Borchhardt K
Vitam Horm; 2011; 86():429-68. PubMed ID: 21419283
[TBL] [Abstract][Full Text] [Related]
10. Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy.
Lai CH; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Vo A; Jordan SC; Reinsmoen NL
Transplantation; 2011 Jul; 92(1):48-53. PubMed ID: 21562450
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.
van Gent R; Metselaar HJ; Kwekkeboom J
Transplant Rev (Orlando); 2017 Apr; 31(2):78-86. PubMed ID: 28131494
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study.
Wei Y; Chen X; Zhang H; Su Q; Peng Y; Fu Q; Li J; Gao Y; Li X; Yang S; Ye Q; Huang H; Deng R; Li G; Xu B; Wu C; Wang J; Zhang X; Su X; Liu L; Xiang AP; Wang C
Front Immunol; 2021; 12():662441. PubMed ID: 34248942
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management.
Ng YW; Singh M; Sarwal MM
Drugs; 2015 Apr; 75(5):455-72. PubMed ID: 25813498
[TBL] [Abstract][Full Text] [Related]
14. The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation.
Merino A; Ripoll E; de Ramon L; Bolaños N; Goma M; Bestard O; Lloberas N; Grinyo JM; Ambròs JT
Cell Transplant; 2017 Jun; 26(6):1017-1030. PubMed ID: 28160460
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-based therapy in kidney transplantation.
Chen C; Hou J
Stem Cell Res Ther; 2016 Feb; 7():16. PubMed ID: 26852923
[TBL] [Abstract][Full Text] [Related]
16. Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial?
Zonta S; De Martino M; Bedino G; Piotti G; Rampino T; Gregorini M; Frassoni F; Dal Canton A; Dionigi P; Alessiani M
Transplant Proc; 2010 May; 42(4):1336-40. PubMed ID: 20534295
[TBL] [Abstract][Full Text] [Related]
17. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival.
Koch M; Lehnhardt A; Hu X; Brunswig-Spickenheier B; Stolk M; Bröcker V; Noriega M; Seifert M; Lange C
Transpl Immunol; 2013 Dec; 29(1-4):43-50. PubMed ID: 23994720
[TBL] [Abstract][Full Text] [Related]
18. The multifaceted role of complement in kidney transplantation.
Biglarnia AR; Huber-Lang M; Mohlin C; Ekdahl KN; Nilsson B
Nat Rev Nephrol; 2018 Dec; 14(12):767-781. PubMed ID: 30367174
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.
Franquesa M; Herrero E; Torras J; Ripoll E; Flaquer M; Gomà M; Lloberas N; Anegon I; Cruzado JM; Grinyó JM; Herrero-Fresneda I
Stem Cells Dev; 2012 Nov; 21(17):3125-35. PubMed ID: 22494435
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads.
Tatapudi VS; Montgomery RA
Front Immunol; 2019; 10():2306. PubMed ID: 31632397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
